The Procter & Gamble Company's Stock Analysis

Procter & Gamble Reports Third Quarter Financial Results for 2026

The Procter & Gamble Company announced its third quarter results for fiscal year 2026, reporting a 3% increase in organic sales compared to the previous year. The company experienced a 2% growth in volume and a 1% increase in pricing, with all product categories and regions showing organic sales growth. Core earnings per share rose to $1.59, a 3% increase from the prior year, while adjusted free cash flow productivity stood at 82%. The company maintained its guidance for organic sales growth between 0% to 4% for the fiscal year.

In the third quarter, the Beauty segment reported a 1% organic sales growth, while Grooming and Health Care segments saw organic sales growth of 1% and 2%, respectively. The Fabric & Home Care segment achieved a 3% organic sales growth, and the Baby, Feminine, and Family Care segment reported a 3% increase. The company noted that net earnings growth was partially offset by unfavorable product mix and increased commodity and tariff costs. Procter & Gamble also plans to allocate approximately $10 billion for capital spending and $5 billion for dividends in fiscal year 2026.

Apr 24, 2026 10:02:12

Procter & Gamble Reports Q3 Fiscal 2026 Financial Results

The Procter & Gamble Company reported third quarter fiscal year 2026 net sales of $21.2 billion, reflecting a seven percent increase compared to the same period last year. Organic sales rose three percent, driven by a two percent increase in volume and one percent from higher pricing. Diluted net earnings per share were $1.63, marking a six percent increase year-over-year, aided by a gain from the dissolution of the Glad joint venture. The company returned $3.2 billion to shareholders through dividends and share repurchases, maintaining its long history of dividend increases.

In terms of segment performance, organic sales growth varied, with the Beauty segment increasing by seven percent and the Grooming segment seeing a one percent rise. The company maintained its fiscal 2026 guidance for all-in sales growth between one and five percent, with diluted net earnings per share growth expected to be between one and six percent. P&G anticipates headwinds from commodity costs and tariffs, estimating a $0.25 per share impact for the fiscal year. Capital spending is projected at four to five percent of net sales, with plans to invest significantly in innovation and demand creation.

Apr 24, 2026 07:01:47

Procter & Gamble Declares Quarterly Dividend Increase for Investors

The Procter & Gamble Company announced a quarterly dividend of $1.0885 per share, marking a three percent increase from the previous quarter. This dividend will be payable on or after May 15, 2026, to shareholders of record as of April 24, 2026. The company has a long-standing history of dividend payments, having paid dividends for 136 consecutive years and increased them for 70 consecutive years.

This announcement highlights Procter & Gamble's commitment to returning cash to shareholders, which may be significant for investors seeking reliable income from their investments. The company operates in approximately 70 countries and offers a wide portfolio of well-known consumer brands, which supports its financial stability and dividend policy.

Apr 14, 2026 16:17:07

Procter & Gamble Reports Q2 FY 2026 Financial Results

On January 22, 2026, Procter & Gamble announced its second quarter results, showing organic sales growth at 0% and a decline in organic volume by 1%. The core earnings per share remained steady at $1.88, consistent with the prior year. Despite challenges, seven out of ten product categories either grew or maintained organic sales. The company’s global market share decreased by 20 basis points, although 25 of the top 50 category/country combinations saw share growth or stability during the quarter.

For FY 2026, Procter & Gamble provided guidance with organic sales growth projected between 0% to 4% and net sales growth between 1% to 5%. The core earnings per share growth is also expected to be in the range of 0% to 4%. The company anticipates potential headwinds from various factors including market deceleration, currency fluctuations, and increased commodity costs, which could affect its financial performance.

Jan 22, 2026 11:53:22

Procter & Gamble Reports Q2 2026 Financial Results and Guidance

Procter & Gamble Company reported net sales of $22.2 billion for the second quarter of fiscal year 2026, reflecting a one percent increase compared to the previous year. Organic sales remained unchanged, with a one percent rise in pricing offset by a one percent decline in unit volume. The company's diluted net earnings per share decreased by five percent to $1.78, primarily due to increased restructuring charges, while core earnings per share remained steady at $1.88. Operating cash flow was reported at $5.0 billion, and the company returned $4.8 billion to shareholders through dividends and share repurchases.

For fiscal year 2026, Procter & Gamble maintained its guidance for all-in sales growth between one to five percent and organic sales growth in the range of in-line to up four percent. The diluted net earnings per share growth outlook was adjusted to a range of one to six percent, reflecting higher restructuring charges. The company expects commodity costs to be neutral for the year and anticipates a tailwind from foreign exchange rates. Procter & Gamble plans to pay around $10 billion in dividends and repurchase approximately $5 billion of common shares during the fiscal year.

Jan 22, 2026 07:02:05

Procter & Gamble Declares Quarterly Dividend of $1.0568 Per Share

The Procter & Gamble Company announced on January 13, 2026, that its Board of Directors has declared a quarterly dividend of $1.0568 per share on its Common Stock, as well as on the Series A and Series B ESOP Convertible Class A Preferred Stock. This dividend is set to be payable on or after February 17, 2026, to shareholders of record as of January 23, 2026.

This marks the continuation of P&G's long-standing practice of returning cash to shareholders, having paid dividends for 135 consecutive years and increased its dividend for 69 consecutive years. The company's commitment to maintaining a reliable income stream for investors is emphasized, highlighting its extensive portfolio of well-known consumer brands and global operations in approximately 70 countries.

Jan 13, 2026 16:27:59

CEO of Procter & Gamble Announces Retirement Effective June 2026

Jennifer Davis, the Chief Executive Officer of Health Care at Procter & Gamble, has announced her intention to retire on June 30, 2026, after over 33 years with the company. This leadership change may impact the company's strategic direction and operations as it prepares for her departure.

The announcement was made on December 9, 2025, and reflects a significant transition within the company's executive team. Investors may want to monitor the company's succession planning and any potential implications for its performance in the health care sector.

Dec 15, 2025 09:15:22

Procter & Gamble Closes $258.9 Million Note Offering

The Procter & Gamble Company has successfully completed an underwritten public offering of Floating Rate Notes, totaling $258,889,000. These notes are due on November 4, 2075 and were issued under the company's existing Registration Statement on Form S-3.

Legal opinions related to the notes have been included as part of the filing. This offering may affect the company's financial position and liquidity, which are key considerations for investors.

Nov 04, 2025 16:16:00

Procter & Gamble Closes €1 Billion and $1.25 Billion Offerings

On November 3, 2025, The Procter & Gamble Company completed an underwritten public offering totaling €500 million in 2.900% Notes due in 2033 and €500 million in 3.650% Notes due in 2045. This issuance was conducted under the company's Registration Statement on Form S-3.

Additionally, the company closed another public offering of $750 million in 4.100% Notes due in 2032 and $500 million in 4.350% Notes due in 2035, also under the same Registration Statement. Legal opinions related to these offerings have been attached as exhibits to the report.

Nov 03, 2025 16:23:10

Procter & Gamble Reports Q1 FY 2026 Financial Results

On October 24, 2025, Procter & Gamble announced its first quarter results for FY 2026, reporting a 2% growth in organic sales driven by pricing and mix, despite a challenging market environment. Core earnings per share (EPS) increased by 3% year-over-year, reaching $1.99, while organic volume growth remained flat. The company noted that 8 out of 10 product categories either grew or maintained their organic sales during this quarter, although the global aggregate value share declined by 30 basis points.

For the fiscal year 2026, Procter & Gamble provided guidance indicating expected organic sales growth of 0% to 4% and net sales growth of 1% to 5%. Core EPS is projected to grow between 0% to 4%, with all-in EPS growth anticipated to be between 3% to 9%. The company also highlighted various potential headwinds that could impact these projections, including commodity cost increases and geopolitical disruptions. Investors may want to consider these factors when assessing the company's outlook.

Oct 24, 2025 10:10:46